Viswanathan Mohan, MD, PhD, Receives American Diabetes Association’s® 2018 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes


Michelle Kirkwood

Arlington, Virginia
May 22, 2018

Viswanathan Mohan, MD, PhD, has been selected to receive the American Diabetes Association's® (ADA's) 2018 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. This award honors individual outstanding service in the cause of diabetes, performed with an international perspective and with international impact. Dr. Mohan will be recognized with this honor at the ADA’s 78th Scientific Sessions, June 22-26, 2018, at the Orange County Convention Center in Orlando.

Dr. Mohan is Chairman and Chief of Diabetology at Dr. Mohan’s Diabetes Specialties Centre at Chennai in South India, a World Health Organization Collaborating Centre for Noncommunicable Diseases Prevention and Control. He also serves as Director of the Madras Diabetes Research Foundation. 

Internationally renowned, Dr. Mohan has worked tirelessly to address the challenges of diabetes in India and developing countries. He is actively involved in Indian Government health policy and advocacy programs related to diabetes, and he has served as President of the Research Society for the Study of Diabetes in India. Dr. Mohan’s comprehensive diabetes center boasts 40 branches with computerized clinical data on more than 400,000 patients. 

“Thank you, Dr. Mohan, for your commitment to serving people with diabetes and to bringing systematic changes to improve populations. Congratulations on this accomplishment,” said the ADA’s 2018 President of Health Care and Education Felicia Hill-Briggs, PhD, ABPP. “Your efforts to ensure that the best diabetes care is available to people in India and other developing countries have improved millions of lives.”

With several productive international research collaborations, Dr. Mohan has contributed to more than 700 original publications. His remarkable reach in training health care providers includes efforts supported by the World Diabetes Foundation (Denmark) and Public Health Foundation of India, through which he has trained more than 20,000 providers in India, Kenya, Tanzania, Nigeria, Uganda, Cambodia, Vietnam, Bhutan, Sri Lanka and Nepal. He also provides lifelong, free treatment to thousands of patients.

The American Diabetes Association’s 78th Scientific Sessions, to be held June 22-26, 2018, at the Orange County Convention Center in Orlando, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, more than 16,000 health care professionals from around the world will have exclusive access to more than 3,000 original diabetes research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight theme areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Felicia Hill-Briggs, PhD, ABPP, President of Health Care and Education, will deliver her address, “The American Diabetes Association in the Era of Health Care Transformation,” on Saturday, June 23, and Jane E.B. Reusch, MD, President of Medicine and Science, will present her address, “24/7/365 – Lifetime with Diabetes,” on Sunday, June 24. In total, the 2018 Scientific Sessions includes 375 oral presentations; 2,117 poster presentations, including 47 moderated poster discussions; and 297 published-only abstracts. Join the Scientific Sessions conversation on social media using #2018ADA.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)